RankingsPricing
  1. JP-listed companies
  2. Sumitomo Pharma Co., Ltd.
  3. Financials
  4. Income before tax

Sumitomo Pharma Co., Ltd.【JP:4506】

Market cap
¥1.16T
P/E ratio
12.6x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndIncome before tax (Million JPY)YoY (%)
Mar 31, 202517,611-105.45%
Mar 31, 2024-323,114+574.28%
Mar 31, 2023-47,920-157.76%
Mar 31, 202282,961+6.56%
Mar 31, 202177,851-7.26%
Mar 31, 202083,947+29.06%
Mar 31, 201965,046-23.35%
Mar 31, 201884,866+56.17%
Mar 31, 201754,341+54.29%
Mar 31, 201635,221+50.96%
Mar 31, 201523,331-42.58%
Mar 31, 201440,631+65.81%
Mar 31, 201324,505+29.85%
Mar 31, 201218,872

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)